Tag: Cancer: Lung
Incidence of Lung Cancer Higher in Women Versus Men Aged 35 to 54 Years
Female-to-male incidence rate ratio increased from 0.73 during 2000 to 2004 to 1.05 during 2015 to 2019
ASTRO: Liquid Biopsy Can Stratify Risk in Oligometastatic NSCLC
Overall, progression-free survival worse for oligometastatic NSCLC patients with versus without detectable ctDNA before radiotherapy
PLCOm2012 Models Have High Sensitivity for Lung Cancer
PLCOm2012 models have higher sensitivity than USPSTF criteria, with no difference by Indigenous classification
Machine Learning Can Better ID Who Needs Lung Cancer Screening
Model relies only on age, smoking duration, and pack-years
Intensity-Modulated Radiation Therapy Best for Locally Advanced NSCLC
Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy
Reproductive Factors Linked to Risk for Lung Cancer
Early menarche, early menopause, shortened reproductive life span linked to increased risk, especially for NSCLC
Removing Race Correction From Lung Function Test Changes Clinical Management
Removal of race correction was tied to a significant reduction in the estimation of lung function for African Americans
Common Cancer Screenings May Not Extend Life Longevity
Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy
Cancer Screening Has Provided Significant Value to U.S. Population
Single-site cancer screening could save an additional 3.2 to 5.1 million life-years with perfect adherence
Atezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo
First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy
